Ana Coroadinha’s remarks on mRNA technology | Visão

[Click here to read the original article]

Ana Coroadinha, Head of Cell Line Development & Molecular Virology Lab, commented the potential application of mRNA technology as a new therapeutic option in an interview for “Visão” magazine .

Coroadinha’s quotes:

“Basically [mRNA] is an intermediary state between our genome and the synthesis of proteins”
“Both antisense RNA oligonucleotides and siRNAs have been widely used in [the treatment of] diseases where mutations originate non-functional proteins, and also on [diseases caused by] protein aggregation”